Search

Your search keyword '"Kearns, PR"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Kearns, PR" Remove constraint Author: "Kearns, PR"
48 results on '"Kearns, PR"'

Search Results

1. Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective

2. The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global

3. Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference

6. The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.

8. Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.

9. Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective.

10. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE.

11. QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer.

13. The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global.

14. The Care of Children With Cancer During the COVID-19 Pandemic.

15. Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project.

16. Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement.

17. A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas.

18. Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trial.

20. Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model.

21. Long-term analysis of children with metastatic neuroblastoma treated in the ENSG5 randomised clinical trial.

22. The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic review.

23. The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review.

24. Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.

25. 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers.

26. Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.

27. From class waivers to precision medicine in paediatric oncology.

28. The development of targeted new agents to improve the outcome for children with leukemia.

29. The impact of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.

30. The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic review.

31. Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain Tumours.

32. The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.

33. Novel therapies for children with acute myeloid leukaemia.

34. Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.

35. PEPtalk: postexposure prophylaxis against varicella in children with cancer.

36. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.

37. Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.

38. Expression of CD133 on leukemia-initiating cells in childhood ALL.

39. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia.

40. Mu class glutathione S-transferase mRNA isoform expression in acute lymphoblastic leukaemia.

41. Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia.

42. Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia.

43. Microtiter plate technique for the measurement of glutathione in fresh and cryopreserved lymphoblasts using the enzyme recycling method.

44. Thromboplastic complication of pregnancy.

Catalog

Books, media, physical & digital resources